865179-75-5

Upstream product

• 97576-74-4 allyl (3,4,6-tri-O-benzyl-α-D-mannopyranosyl)-(1->2)-3,4,6-tri-O-benzyl-α-D-mannopyranoside 
• 189182-66-9 2-O-acetyl-3,4,6-tri-O-benzyl-D-glucopyranosyl trichloroacetimidate 

Downstream Products

• 865179-76-6 allyl (3,4,6-tri-O-benzyl-β-D-glucopyranosyl)-(1->2)-(3,4,6-tri-O-benzyl-α-D-mannopyranosyl)-(1->2)-3,4,6-tri-O-benzyl-α-D-mannopyranoside 

Relevant academic research and scientific papers

SYNTHETIC ANTI-CANDIDA ALBICANS OLIGOSACCHARIDE BASED VACCINES

The present invention provides immunogenic oligosaccharide compositions and methods of making and using them. In particular, the compositions comprise native O-linked and S-linked oligosaccharides coupled to a protein carrier via a linker, wherein the res

Synthesis of glycoconjugate vaccines for Candida albicans using novel linker methodology

The cell wall phosphomannan of Candida species is a complex N-linked glycoprotein with a glycan chain that contains predominantly α-linked mannose residues. However, it is the minor β-mannan component of the phosphomannan of clinically important Candida s